A prospective longitudinal 6-year study of 34 patients with Parkinson's dis
ease from the time of initiation of drug treatment explored changes in the
motor response to L-dopa over the early to mid disease course. Motor fluctu
ations developed in 41% after a mean L-dopa treatment interval of 25 months
and dyskinesia developed in 53% after a mean of 15 months' treatment. Pati
ents who developed fluctuations had a significantly better response to L-do
pa than nonfluctuators. Nonfluctuators also had significantly greater "midl
ine" motor disability affecting cranial and truncal muscles and gait. The d
evelopment of motor fluctuations may simply reflect a retained capacity to
respond to L-dopa as endogenous dopaminergic neurotransmission declines wit
h progressive nigral cell loss. Many patients who show no sign of motor flu
ctuation 5 or 6 years into the disease course have a relatively blunted res
ponse to L-dopa. The proportion of such cases seems to correspond to the pe
rcentage that have coexisting striatal pathologic changes in postmortem stu
dies.